We conclude that the increased plasma TG levels observed in cd36 -/-mice do not result from an increased hepatic VLDL-TG production or intestinal lipid absorption, but are caused by decreased LPL-mediated hydrolysis of TG-rich lipoproteins resulting from FFA-induced product inhibition of LPL.
Introduction
CD36, also known as fatty acid translocase (FAT) (1) , is a receptor for several ligands, including oxidized LDL and long-chain FFAs (1-5). Abumrad et al. (1) showed that CD36 is abundant in peripheral tissues active in FFA metabolism, such as adipose tissue, skeletal muscle, and cardiac muscle, where it is involved in highaffinity uptake of FFA (1;6;7). To directly investigate a role for CD36 in lipid metabolism, mice lacking CD36 were generated by gene-targeting (8) . These CD36-deficient (cd36 -/-) mice exhibited increased plasma FFA and triglyceride (TG) levels (8) . Coburn et al. (9) showed that FFA uptake was considerably impaired in muscle and adipose tissue of CD36-deficient mice. Febbraio et al. (8) further showed that the increase in plasma TG levels in the absence of CD36 was primarily due to an increase in VLDL-sized particles. Although these data suggest a role for CD36 in TG metabolism in addition to FFA metabolism, the exact mechanism(s) underlying the increased TG levels in cd36 -/-mice is (are) unknown. It has been discussed by Hajri et al. (10) that the VLDL production rate may be enhanced in CD36-deficient mice, but the increased plasma TG levels may also be due to increased intestinal lipid absorption or a decreased lipoprotein lipase (LPL)-mediated TG clearance from the circulation.
Therefore, the aim of the present study was to elucidate the cause of the hypertriglyceridemia in CD36-deficient mice in vivo. Our results show that the increased plasma TG levels in cd36 -/-mice are caused by a decreased TG hydrolysis rate, rather than by differences in the production of hepatic VLDL-TG or intestinal lipid absorption. From the present study we conclude that the hypertriglyceridemia observed in cd36 -/-mice is caused by decreased LPL-mediated hydrolysis of TG-rich lipoproteins resulting from FFA-induced product inhibition.
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MATERIALS AND METHODS

Animals
CD36-deficient mice were generated by targeted homologous recombination and crossed back 6 times to C57Bl/6 background (8) . Male and female cd36 -/-mice (4-6 months of age) were used with wild-type littermates (cd36 +/+ ) as controls. They were housed under standard conditions with free access to water and food (standard ratmouse chow diet, Standard Diet Services, Essex, UK). Principles of laboratory animal care were followed and the animal ethics committee of our institute approved all animal experiments.
Plasma TG and FFA analysis
To determine plasma lipid levels, tail vein blood was collected from male cd36 -/-and cd36 +/+ mice, after 4 h and 16 h fasting, into chilled paraoxon-coated capillary tubes to prevent ongoing lipolysis (11) . These tubes were placed on ice and immediately centrifuged at 4°C. Plasma levels of TG (without free glycerol) and FFA were determined using the commercially available kits #337-B Sigma GPO-Trinder kit (Sigma, St. Louis, MA, USA) and Nefa-C kit (Wako Chemicals GmbH, Neuss, Germany), respectively.
Hepatic VLDL production
After an overnight fast, cd36 -/-and cd36 +/+ male mice were anesthetized (0.5 mL/kg hypnorm; Janssen Pharmaceutical, Beerse, Belgium and 12.5 mg/kg midazolam;
Roche, Mijdrecht, The Netherlands), and injected intravenously into the tail vein with 500 mg Triton WR1339 per kg body weight as a 10% solution in 0.9% NaCl, which virtually completely inhibits serum lipoprotein clearance (12) . Blood samples were drawn at 0, 15, 30, 60, and 90 min after the Triton injection and TG concentrations were determined in plasma as described above and related to the body mass of the mice.
Intestinal lipid absorption
To study the intestinal lipid uptake, Plasma volumes were calculated according to Rensen et al. (13) .
Intragastric fat load
To investigate the handling of postprandial TG, male cd36 -/-and cd36 +/+ mice, after 2 weeks on a high-fat diet and an overnight fast, were given an intragastric 200 µL olive oil bolus. Blood samples were drawn at 0, 1, 2, 4, 6, and 8.5 h after bolus administration, and FFA and TG concentrations were determined in plasma as described above and corrected for the plasma FFA and TG levels at t=0.
Plasma LPL and hepatic lipase levels
Plasma was obtained from male cd36 -/-and cd36 +/+ mice, after 2 weeks on a high-fat diet (46.2% of the calories as fat, Hope Farms, Woerden, the Netherlands) and an overnight fast, at 10 min after a tail vein injection of heparin (0.1 units/g body weight,
Leo Pharma BV, Weesp, The Netherlands). To prevent excessive plasma lipolysis the capillaries we used to sample the postheparin plasma were kept on ice, spun immediately at 4°C and snap-frozen in liquid nitrogen. Plasma LPL and hepatic lipase (HL) levels were determined in postheparin plasma as described (14) . In short, the lipolytic activity of plasma was assessed by determination of [ 3 H]oleate production upon incubation of plasma with a substrate mix containing an excess of both 
Modulated plasma LPL and HL activities
Plasma was obtained from male cd36 -/-and cd36 +/+ mice, after 2 weeks on a high-fat diet and an overnight fast, at 10 min after a tail vein injection of heparin (0.1 U/g). (15) . Under these assay conditions, TG derived from mouse plasma contributed only marginally to the total TG present in the incubations (approx. 1%).
Clearance of TG-rich VLDL-like emulsion particles 
Statistical analysis
The Mann-Whitney nonparametric test for 2 independent samples was used to define differences between cd36 -/-and cd36 +/+ mice. The criterion for significance was set at P<0.05. All data are presented as means ± SD.
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RESULTS
Increased plasma TG levels in cd36 -/-mice
In accordance with previously published data (8;9), cd36 -/-mice bred at our local facility exhibited significantly increased fasting plasma FFA levels compared to wildtype littermates (0.89 ± 0.07 and 0.52 ± 0.09 mM, respectively; P<0.05). Table 1 summarizes the plasma TG levels in male cd36 -/-and wild-type mice as observed by us and others (8;10). On average, cd36 -/-mice exhibited significantly 1.3-1.4-fold increased plasma TG levels compared to wild-type mice after various fasting periods and dietary treatments ( Table 1) .
Hepatic VLDL-TG production is not affected in CD36 deficiency
The increased plasma TG levels in cd36 -/-mice can be due either to i) increased hepatic VLDL-TG production, ii) increased intestinal lipid absorption, or iii) decreased lipolysis and/or clearance of TG from the circulation. To evaluate the effect of CD36-deficiency on hepatic VLDL production, cd36 -/-mice and wild-type mice were injected with Triton WR1339 to block LPL-mediated TG hydrolysis, and the accumulation of endogenous VLDL-TG in plasma was monitored over time. Figure 1 shows that CD36 deficiency did not affect the VLDL-TG production rate (40.9 ± 12.9 versus 40.2 ± 1.9 µmol TG.kg -1 .h -1 ). Consistently, we did not observe any difference in the composition of nascent VLDL that was isolated at 90 min after Triton WR1339 treatment (not shown).
Intestinal lipid absorption is not affected in CD36 deficiency
We next investigated whether the increased plasma TG levels in CD36 deficiency could be due to increased intestinal lipid absorption. Goudriaan et al. 8
Apparently, the elevated TG levels in cd36 -/-mice cannot be explained by an increased VLDL-TG production or intestinal TG absorption. Therefore, to get more insight into the underlying mechanism, we severely stressed TG metabolism by giving mice an intragastric fat load, and monitored the appearance of TG and FFA in plasma ( Figure 3) . Remarkably, the postprandial TG response was 2-fold enhanced in cd36 -/-mice as compared to wild-type littermates (AUC 0-8.5 h : 13 ± 6 and 7 ± 2 mM.h, respectively; P<0.05), which suggests that CD36 deficiency results in impaired lipolytic conversion of postprandial TG in plasma ( Figure 3A) . Interestingly, FFA levels were also 2.5-fold elevated as compared to wild-type littermates (AUC 0-8.5 h : 20 ± 6 and 8 ± 1 mM.h, respectively; P<0.05; Figure 3B ).
CD36 deficiency does not modulate plasma LPL levels
Since the elevated plasma TG levels in cd36 -/-mice may thus be explained by a decreased LPL-mediated TG hydrolysis, the levels of LPL and HL were measured in post-heparin plasma of cd36 -/-and wild-type mice ( Figure 4 ). However, CD36
deficiency did not affect the total plasma LPL or HL levels as determined by their TG hydrolase activity.
Increased plasma FFA levels in CD36 deficiency decreases LPL activity
Since CD36-deficient mice have elevated FFA levels, which are severely increased to approximately 5 mM after an intragastric fat load (Figure 3 ), we speculated that these elevated FFAs might interfere with the activity of LPL in plasma. Therefore, we determined the FFA-modulated LPL and HL activities of plasma from cd36 -/-and wild-type mice in the absence of excess albumin ( Figure 5A ). In this setting, although the total lipolysis of [ 3 H]triolein-labeled emulsion particles as induced by plasma of cd36 -/-mice was not significantly decreased, the LPL activity was indeed decreased by 51% (0.13 ± 0.06 vs 0.27 ± 0.07 nmol oleate/mL/min; P<0.05). However, as shown in Figure 5B , the addition of excess FFA-free albumin relieved this inhibition of LPL activity in cd36 -/-mice (1.31 ± 0.32 vs 0.80 ± 0.40 nmol oleate/mL/min;
P=0.055). Cd36
-/-mice even show an increased total TG hydrolase activity probably due to the increased plasma TG levels (1.54 ± 0.25 vs 1.10 ± 0.32 nmol oleate/mL/min; P<0.05). Collectively, these data suggest that the increased Goudriaan et al. 10
DISCUSSION
In agreement with observations by others (8-10), we have shown that absence of the fatty acid translocase CD36 in mice leads to increased plasma FFA levels concomitant with 30-40% increased TG levels. The effect of CD36 deficiency on increased plasma FFA levels can easily be explained by an impaired peripheral uptake (9) . Although it has been postulated that the VLDL production rate may be enhanced in CD36 deficient mice (10), the mechanism underlying the effect of CD36 on TG metabolism had not been addressed yet. The results of the present study clearly show that the hypertriglyceridemia observed in cd36 -/-mice is caused by a decreased LPL-mediated TG hydrolysis rate induced by increased plasma FFA levels, rather than by an increased production of hepatic VLDL-TG or increased intestinal lipid absorption.
Recently, we have shown that the increased plasma FFA levels in CD36-deficient mice lead to an enhanced FA flux towards the liver, resulting in increased TG storage (hepatic steatosis) (16) . Hepatic VLDL production is thought to be primarily a substrate-driven process, regulated by the availability of FFA (reviewed by Lewis et al. (17) ). Furthermore, acute elevation of plasma FFA levels stimulates VLDL production in humans (18) . Therefore, the increased FFA flux to the liver in CD36 deficiency (16) confirming observations from our earlier study (23) .
To get more insight into the mechanism underlying the observed hypertriglyceridemia in CD36-deficient mice, we severely stressed TG metabolism by giving mice an intragastric fat load, resulting in a rapid and extensive generation of chylomicrons. Remarkably, the postprandial TG response was 2-fold enhanced in , respectively; P<0.05). In our study we also show in vivo that in wild-type mice 1.4-fold increased plasma FFA levels lead to a decreased capacity of LPL to lipolyze VLDL-TG. In the short time frame in which the experiment was performed it is very unlikely that other LPL modulators such as apoCII or apoCIII have changed between groups and impair the LPL-mediated TG clearance. Slight changes in plasma concentrations of these modulators cannot be excluded in the case of the cd36 -/-mice. However, our collective findings that 1) the inhibition of LPL activity by plasma from CD36-deficient mice is relieved by addition of the FFA-sequestrant BSA, and 2) elevation of plasma FFA levels by infusion impairs TG clearance, strongly suggest that the hypertriglyceridemic phenotype of CD36-deficient mice is indeed mainly explained by increased FFA levels.
These effects of increased plasma FFA on tissue LPL activity may be explained by several mechanisms. Binding of FFA to the active site of LPL might cause classical product inhibition of LPL activity. We and others (25) showed in vitro that the rate at which LPL hydrolyzes TG in lipoproteins or emulsions particles decreases sharply with the amount of FFA formed unless albumin is present. An alternative mechanism has been proposed by Saxena and Goldberg (26) who showed in vitro that plasma FFA levels may be important modulators of LPL interaction with the endothelial cell surface and apoCII. In vivo evidence for a role of plasma FFA in the control of LPL was proposed in humans. Peterson et al. (27) suggested that LPL is subject to feedback control by FFA, involving an unusual mechanism that FFA may regulate not only the catalytic activity of the enzyme but also its distribution between endothelial sites (27) .
In summary, in the present study we show that the increased plasma TG levels in CD36 deficiency are not due to a previously hypothesized enhancing effect on VLDL production or to an effect on intestinal lipid absorption. Instead, CD36
deficiency resulted in hypertriglyceridemia caused by decreased LPL-mediated hydrolysis of TG-rich lipoproteins resulting from FFA-induced product inhibition.
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